DNLI logo

Denali Therapeutics Inc. (DNLI) EV/EBITDA

EV/EBITDA:

-2.66+0.04(+1.48%)
September 9, 2025

Summary

  • As of today (September 10, 2025), DNLI EV/EBITDA is -2.66, with a rise of +0.04 (+1.48%) during the most recent trading session on September 9, 2025.
  • Over the past year, DNLI EV/EBITDA has increased by +3.13 (+54.06%).
  • DNLI EV/EBITDA is now -101.44% below its all-time high of 184.29.

Performance

DNLI EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherDNLIvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

DNLI EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+1.5%-1.4%-0.9%
1 m1 month-17.2%+17.2%+10.0%
3 m3 months+0.8%+2.6%+4.9%
6 m6 months+20.1%-15.3%-8.0%
ytdytd+39.1%-35.5%-24.6%
1 y1 year+54.1%-50.5%-40.0%
5 y5 years+79.5%-51.4%-51.3%

DNLI EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-2.06-29.1%-2.74+2.9%
3 m3-month-2.06-29.1%-2.85+6.7%
6 m6-month-1.77-50.3%-3.33+20.1%
1 y1-year-1.77-50.3%-7.58+64.9%
3 y3-year-1.77-50.3%-20.31+86.9%
5 y5-year184.29-101.4%-44.64+94.0%
alltimeall time184.29-101.4%-59.99+95.6%

DNLI EV/EBITDA History

DateValue
2025
-2.66(-39.1%)
2024
-4.37(-60.0%)
2023
-10.93(+45.5%)
2022
-7.51(-53.2%)
DateValue
2021
-16.04(-112.9%)
2020
124.45(-2000.0%)
2019
-6.55(-86.2%)
2018
-47.48(+118.4%)
2017
-21.74

FAQ

  • What is Denali Therapeutics Inc. EV/EBITDA?
  • What is the all time high EV/EBITDA for Denali Therapeutics Inc.?
  • What is DNLI EV/EBITDA year-to-date change?
  • What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?

What is Denali Therapeutics Inc. EV/EBITDA?

The current EV/EBITDA of DNLI is -2.66

What is the all time high EV/EBITDA for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high EV/EBITDA is 184.29

What is DNLI EV/EBITDA year-to-date change?

Denali Therapeutics Inc. EV/EBITDA has changed by +1.71 (+39.13%) since the beginning of the year

What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?

Over the past year, DNLI EV/EBITDA has changed by +3.13 (+54.06%)
On this page